Filing Details
- Accession Number:
- 0001127602-12-018620
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-30 20:44:58
- Reporting Period:
- 2012-05-29
- Filing Date:
- 2012-05-30
- Accepted Time:
- 2012-05-30 20:44:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 850693 | Allergan Inc | AGN | Pharmaceutical Preparations (2834) | 951622442 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1298861 | M Trevor Jones | 2525 Dupont Drive Irvine CA 92612 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-05-29 | 1,500 | $91.12 | 23,327 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-05-29 | 1,000 | $51.72 | 24,327 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-05-29 | 1,000 | $91.15 | 23,327 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Nonemployee Director Stock Option (Right to Buy) | Disposition | 2012-05-29 | 1,000 | $0.00 | 1,000 | $51.72 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,000 | 2007-05-02 | 2016-05-02 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 10, 2012.
- Includes 4,800 shares of the Issuer's common stock underlying the RSUs awarded.
- Includes shares issued pursuant to the dividend equivalent rights, exempt transaction under Rule 16a-11.
- Option is fully vested and exercisable on the one year (1) year anniversary of its grant.
Billionaire Hedge Funds
